1. Home
  2. RBBN vs KALA Comparison

RBBN vs KALA Comparison

Compare RBBN & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.81

Market Cap

382.8M

Sector

Technology

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.20

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
KALA
Founded
1997
2009
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.8M
319.6M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
RBBN
KALA
Price
$2.81
$0.20
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$4.67
$31.50
AVG Volume (30 Days)
769.4K
2.6M
Earning Date
04-28-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
170.97
67.39
EPS
0.22
N/A
Revenue
N/A
N/A
Revenue This Year
$1.97
N/A
Revenue Next Year
$6.69
N/A
P/E Ratio
$12.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$0.15
52 Week High
$4.29
$20.58

Technical Indicators

Market Signals
Indicator
RBBN
KALA
Relative Strength Index (RSI) 73.17 42.86
Support Level $2.69 $0.15
Resistance Level $2.88 $0.72
Average True Range (ATR) 0.12 0.02
MACD 0.07 0.01
Stochastic Oscillator 97.47 62.84

Price Performance

Historical Comparison
RBBN
KALA

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: